Eric Adams
Director Ejecutivo en INMED PHARMACEUTICALS INC. .
Fortuna: 11 693 $ al 30/06/2024
Cargos activos de Eric Adams
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
INMED PHARMACEUTICALS INC. | Director/Miembro de la Junta | 16/06/2016 | - |
Director Ejecutivo | 16/06/2016 | - | |
Presidente | 16/06/2016 | - |
Historial de carrera de Eric Adams
Antiguos cargos conocidos de Eric Adams.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Ronin8 Technologies Ltd.
Ronin8 Technologies Ltd. Environmental ServicesIndustrial Services Ronin8 Technologies Ltd. provides materials recovery facilities. It captures the metals in electronic waste without destroying the non-metals. The company was founded by Bruce Sifton and Peter Holgate in 2015 and is headquartered in Vancouver, Canada. | Director Ejecutivo | 01/11/2014 | 01/02/2015 |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | Director/Miembro de la Junta | 25/05/2011 | 01/07/2013 |
Director Ejecutivo | 15/03/2004 | 01/07/2013 | |
Presidente | 15/03/2004 | 25/10/2011 | |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Ventas & Marketing | 01/02/1998 | 01/12/2002 |
ABBOTT LABORATORIES | Corporate Officer/Principal | 01/08/1992 | 01/08/1996 |
FRESENIUS SE & CO. KGAA | Corporate Officer/Principal | 01/06/1988 | 01/06/1992 |
Formación de Eric Adams.
University of South Carolina | Graduate Degree |
University of Southern Indiana | Undergraduate Degree |
Estadísticas
Internacional
Canadá | 5 |
Estados Unidos | 4 |
Alemania | 2 |
Operativa
Chief Executive Officer | 3 |
Director/Board Member | 2 |
President | 2 |
Sectorial
Health Technology | 5 |
Consumer Services | 3 |
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
ABBOTT LABORATORIES | Health Technology |
FRESENIUS SE & CO. KGAA | Health Technology |
INMED PHARMACEUTICALS INC. | Health Technology |
Empresas privadas | 3 |
---|---|
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | Health Technology |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Commercial Services |
Ronin8 Technologies Ltd.
Ronin8 Technologies Ltd. Environmental ServicesIndustrial Services Ronin8 Technologies Ltd. provides materials recovery facilities. It captures the metals in electronic waste without destroying the non-metals. The company was founded by Bruce Sifton and Peter Holgate in 2015 and is headquartered in Vancouver, Canada. | Industrial Services |
- Bolsa de valores
- Insiders
- Eric Adams
- Experiencia